Characterization of new substrates targeted by Yersinia tyrosine phosphatase YopH

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  de la Puerta, María Luisa ^a   Trinidad, Antonio G ^a   Rodríguez, María del Carmen ^a   Bogetz, Jori ^b   Crespo, Mariano Sánchez ^a   Mustelin, Tomas ^b   Alonso, Andrés ^a   Bayón, Yolanda ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; FYN BINDING PROTEIN; GRB2 ASSOCIATED BINDER 1; GRB2 ASSOCIATED BINDER 2; PROTEIN KINASE LCK; PROTEIN P85; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE YOPH; UNCLASSIFIED DRUG; VAV PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; YERSINIA PESTIS; YERSINIOSIS;

BACTERIA (MICROORGANISMS); YERSINIA; YERSINIA PESTIS;

EID: 84887212578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004431     Document Type: Article

References (37)

1. Titball RW, Leary SE (1998) Plague. Br Med Bull 54: 625-633.
2. Hinnebusch BJ (1997) Bubonic plague: a molecular genetic case history of the emergence of an infectious disease. J Mol Med 75: 645-652.
3. Christie AB (1982) Plague: review of ecology. Ecol Dis 1: 111-115.
4. Cleri DJ, Vernaleo JR, Lombardi LJ, Rabbat MS, Mathew A, et al. (1997) Plague pneumonia disease caused by Yersinia pestis. Semin Respir Infect 12: 12-23.
5. Titball RW, Williamson ED (2001) Vaccination against bubonic and pneumonic plague. Vaccine 19: 4175-4184.
6. Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, et al. (1995) Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis 21 Suppl 2: S178-181.
7. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, et al. (1998) The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62: 1315-1352.
8. Cornelis GR, Wolf-Watz H (1997) The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 23: 861-867.
9. Cornelis GR (2000) Molecular and cell biology aspects of plague. Proc Natl Acad Sci U S A 97: 8778-8783.
10. Cheng LW, Schneewind O (2000) Yersinia enterocolitica TyeA, an intracellular regulator of the type III machinery, is required for specific targeting of YopE, YopH, YopM, and YopN into the cytosol of eukaryotic cells. J Bacteriol 182: 3183-3190.
11. Persson C, Nordfelth R, Holmstrom A, Hakansson S, Rosqvist R, et al. (1995) Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell. Mol Microbiol 18: 135-150.
12. Guan KL, Dixon JE (1990) Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249: 553-556.
13. Bliska JB, Guan KL, Dixon JE, Falkow S (1991) Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci U S A 88: 1187-1191.
14. Stuckey JA, Schubert HL, Fauman EB, Zhang ZY, Dixon JE, et al. (1994) Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate. Nature 370: 571-575.
15. Montagna LG, Ivanov MI, Bliska JB (2001) Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition. J Biol Chem 276: 5005-5011.
16. Evdokimov AG, Tropea JE, Routzahn KM, Copeland TD, Waugh DS (2001) Structure of the N-terminal domain of Yersinia pestis YopH at 2.0 A resolution. Acta Crystallogr D Biol Crystallogr 57: 793-799.
17. Black DS, Bliska JB (1997) Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. Embo J 16: 2730-2744.
18. Persson C, Carballeira N, Wolf-Watz H, Fallman M (1997) The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. Embo J 16: 2307-2318.
19. Andersson K, Carballeira N, Magnusson KE, Persson C, Stendahl O, et al. (1996) YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol Microbiol 20: 1057-1069.
20. Ernst JD (2000) Bacterial inhibition of phagocytosis. Cell Microbiol 2: 379-386.
21. Aepfelbacher M, Zumbihl R, Ruckdeschel K, Jacobi CA, Barz C, et al. (1999) The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense. Biol Chem 380: 795-802.
22. Green SP, Hartland EL, Robins-Browne RM, Phillips WA (1995) Role of YopH in the suppression of tyrosine phosphorylation and respiratory burst activity in murine macrophages infected with Yersinia enterocolitica. J Leukoc Biol 57: 972-977.
23. Yao T, Mecsas J, Healy JI, Falkow S, Chien Y (1999) Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med 190: 1343-1350.
24. Hamid N, Gustavsson A, Andersson K, McGee K, Persson C, et al. (1999) YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb Pathog 27: 231-242.
25. Black DS, Marie-Cardine A, Schraven B, Bliska JB (2000) The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cell Microbiol 2: 401-414.
26. Alonso A, Bottini N, Bruckner S, Rahmouni S, Williams S, et al. (2004) Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH. J Biol Chem 279: 4922-4928.
27. Gerke C, Falkow S, Chien YH (2005) The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J ExpMed 201: 361-371.
28. Viboud GI, Bliska JB (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69-89.
29. Bliska JB, Clemens JC, Dixon JE, Falkow S (1992) The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage. J Exp Med 176: 1625-1630.
30. Ivanov MI, Stuckey JA, Schubert HL, Saper MA, Bliska JB (2005) Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence. Mol Microbiol 55: 1346-1356.
31. Koyasu S (2003) The role of PI3K in immune cells. Nat Immunol 4: 313-319.
32. Hazeki K, Nigorikawa K, Hazeki O (2007) Role of phosphoinositide 3-kinase in innate immunity. Biol Pharm Bull 30: 1617-1623.
33. Sauvonnet N, Lambermont I, van der Bruggen P, Cornelis GR (2002) YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositol 3-kinase pathway. Mol Microbiol 45: 805-815.
34. Sarmay G, Angyal A, Kertesz A, Maus M, Medgyesi D (2006) The multiple function of Grb2 associated binder (Gab) adaptor/scaffolding protein in immune cell signaling. Immunol Lett 104: 76-82.
35. Bustelo XR (2001) Vav proteins, adaptors and cell signaling. Oncogene 20: 6372-6381.
36. Hornstein I, Alcover A, Katzav S (2004) Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16: 1-11.
37. Jascur T, Gilman J, Mustelin T (1997) Involvement of phosphatidylinositol 3-kinase in NFAT activation in T cells. J Biol Chem 272: 14483-14488.